Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

The pharmaceutical industry can be a tough business. Companies must innovate constantly to stay relevant because patents ...

The equity is pulling back slightly today, though it remains well above its Nov. 15 dip to $24.48 -- its lowest mark since ...

Below is a chart showing PFE's trailing twelve month trading history, with the $27.00 strike highlighted in red: Considering the fact that the $27.00 strike represents an approximate 4% premium to ...

Check the time stamp on this data. Updated AI-Generated Signals for Pfizer Inc. (PFE) available here: PFE.

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The company has a forward P/E ratio of 11.5 while Merck, Eli Lilly, and Novo Nordisk have multiples of 14.8, 64, and 40.5.

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...